Oncotarget

Commentaries:

Exploiting p53 Status to Enhance Effectiveness of Chemotherapy by Lowering Associated Toxicity

PDF |  HTML  |  How to cite

Oncotarget. 2011; 2:109-112. https://doi.org/10.18632/oncotarget.247

Metrics: PDF 2297 views  |   HTML 3604 views  |   ?  

Linda S. Steelman, Alberto M. Martelli, Ferdinando Nicoletti and James A. McCubrey _

Abstract

Linda S. Steelman1, Alberto M. Martelli2,3, Ferdinando Nicoletti4, and James A. McCubrey1

1 Department of Microbiology & Immunology Brody School of Medicine at East Carolina University Greenville, NC 27858 USA

2 Dipartimento di Scienze Anatomiche Umane e Fisiopatologia dell'Apparato Locomotore Università di Bologna, Bologna, Italy

3 IGM-CNR, Sezione di Bologna, C/o IOR, Bologna, Italy

4 Department of Biomedical Sciences University of Catania, Catania, Italy

Commentary On: Exploring long-term protection of normal human fibroblast and epithelial cells from chemotherapy in cell culture

Keywords : mTOR, Nutlins, Metformin, Taxol, Nacodazole

Received: March 25, 2011; Accepted: March 28, 2011; Published: March 28, 2011;

Correspondence:

James A. McCubrey, e-mail:



Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 247